| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Ma Songjiang is a President at GYRE THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $17.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 2,558 | $10.23 | $26,179.06 | - | -17.8% | -39.2% | |
| May 23, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 2,182 | $10.91 | $23,803.68 | - | -13.0% | -30.2% | |
| May 21, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 4,000 | $11.04 | $44,160.00 | - | -27.4% | -40.4% | |
| May 19, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 4,000 | $11.21 | $44,840.00 | - | -29.3% | -43.7% | |
| May 15, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 2,020 | $10.69 | $21,586.00 | - | -25.0% | -40.1% | |
| May 13, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 4,000 | $10.97 | $43,860.00 | - | -38.5% | -36.7% | |
| Mar 21, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 174 | $10.00 | $1,740.00 | - | -16.9% | -30.8% | |
| Mar 20, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 4,000 | $10.11 | $40,440.00 | - | -18.5% | -34.2% | |
| Mar 18, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 2,242 | $11.89 | $26,658.08 | - | -6.3% | -18.2% | |
| Mar 14, 2025 | GYRE Gyre Therapeutics, Inc. | President | Sell | 4,000 | $12.06 | $48,220.00 | - | -33.4% | -37.6% |